Jacobs Levy Equity Management’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.4M Buy
2,474,423
+1,413,999
+133% +$19.9M 0.12% 175
2025
Q4
$15.2M Buy
1,060,424
+756,821
+249% +$13.1M 0.06% 248
2025
Q3
$5.75M Buy
303,603
+71,932
+31% +$1.19M 0.02% 400
2025
Q2
$4.97M Buy
231,671
+27,747
+14% +$412K 0.02% 434
2025
Q1
$2.67M Sell
203,924
-1,537,382
-88% -$22.8M 0.01% 593
2024
Q4
$23.4M Buy
1,741,306
+477,634
+38% +$7.69M 0.08% 206
2024
Q3
$26.8M Buy
1,263,672
+27,088
+2% +$488K 0.1% 188
2024
Q2
$19.6M Buy
+1,236,584
New +$22.7M 0.08% 223
2024
Q1
Sell
-54,008
Closed -$494K 1021
2023
Q4
$494K Sell
54,008
-291,092
-84% -$2.01M ﹤0.01% 828
2023
Q3
$1.92M Buy
+345,100
New +$2.41M 0.01% 561
2023
Q2
Sell
-37,505
Closed -$245K 1051
2023
Q1
$245K Sell
37,505
-1,642,475
-98% -$6.71M ﹤0.01% 889
2022
Q4
$4.13M Buy
1,679,980
+725,494
+76% +$2.27M 0.03% 433
2022
Q3
$4.76M Buy
954,486
+194,671
+26% +$1.14M 0.04% 401
2022
Q2
$3.23M Buy
+759,815
New +$4.84M 0.03% 501

Other funds holding OSCR